Transfer learning with multiomics integration and deep neural networks reveals drug resistance mechanisms in cancer

Semih Alpsoy1,2, Osman Ugur Sezerman3

  • 1Department of Molecular Biotechnology, Türkisch-Deutsche Universität, Istanbul, Turkey.

Scientific Reports
|November 27, 2025
PubMed

Insights

This study uses deep learning and multi-omics data to predict cancer drug response and identify resistance mechanisms. The approach successfully predicted drug sensitivity and revealed key pathways involved in resistance for several common cancer drugs.

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Drug resistance is a major obstacle in cancer therapy.
  • Predicting drug response and understanding resistance mechanisms are crucial for personalized medicine.

Purpose of the Study:

  • To develop a deep neural network (DNN)-based transfer learning (TL) approach for predicting cancer drug response.
  • To uncover molecular mechanisms underlying drug resistance using multi-omics integration (MI).

Main Methods:

  • Integrated gene expression, somatic mutation, and copy number aberration (CNA) data with drug response profiles.
  • Employed a DNN-based TL approach trained on Genomics of Drug Sensitivity in Cancer (GDSC) data.
  • Validated predictions on independent in-vivo PDX Encyclopedia (PDX) and ex-vivo Cancer Genome Atlas (TCGA) datasets.
  • Conducted pathway enrichment analyses and Fisher's exact test (FET) to identify resistance mechanisms and associations with mutations/CNAs.

Main Results:

  • The pan-drug models achieved superior performance in predicting drug response (AUCPR).
  • Identified LDHB-mediated pyruvate metabolism and FYN-mediated focal adhesion in paclitaxel resistance, and PINK1-mediated mitophagy in 5-FU resistance.
  • Found associations between CNAs in LDHB and PINK1 and resistance to paclitaxel and 5-FU, respectively.
  • Discovered shared resistance mechanisms between paclitaxel and cetuximab.

Conclusions:

  • The DNN-based TL approach demonstrates strong predictive power for drug response across diverse datasets.
  • Pathway enrichment analyses provide significant biological insights into complex drug resistance mechanisms.
  • Findings are consistent with existing literature, validating the model's utility in cancer research.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K